BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Zhou X, He Y, Liao C. SLC6A1-miR133a-CDX2 loop regulates SK-OV-3 ovarian cancer cell proliferation, migration and invasion. Oncol Lett 2018;16:4977-83. [PMID: 30250563 DOI: 10.3892/ol.2018.9273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun T, Bi F, Liu Z, Yang Q. SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer. Aging (Albany NY) 2020;12:13281-96. [PMID: 32647070 DOI: 10.18632/aging.103433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Zhang DD, Wang WE, Ma YS, Shi Y, Yin J, Liu JB, Yang XL, Xin R, Fu D, Zhang WJ. A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma. Cancer Manag Res 2021;13:5063-75. [PMID: 34234551 DOI: 10.2147/CMAR.S308986] [Reference Citation Analysis]
3 Wang QQ, Wei Y, Luo LP, Li X, Jiang WJ. Integrated Analysis of DNA Repair Genes Identifies SLC6A1 as a New Marker for the Clinical Outcome of Patients with Colorectal Cancer. Dis Markers 2022;2022:4952812. [PMID: 35251372 DOI: 10.1155/2022/4952812] [Reference Citation Analysis]